Vaxart Stock Price

-0.38 (-6.99%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Vaxart Inc VXRT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.38 -6.99% 5.06 19:48:48
Close Price Low Price High Price Open Price Previous Close
5.00 4.93 5.2881 5.2163 5.44
Bid Price Ask Price Spread News
5.06 5.10 0.04 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
21,324 5,268,563 $ 5.05 $ 26,617,035 16,314,941 0.266 - 17.49
Last Trade Time Type Quantity Stock Price Currency
19:48:48 formt 3,158 $ 5.06 USD

Vaxart Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 558.29M 109.47M 83.54M $ 9.86M $ - -0.79 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 170.69k 2.80%

more financials information »

Vaxart News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VXRT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.325.654.935.385,648,788-0.26-4.89%
1 Month6.748.434.936.629,807,267-1.68-24.93%
3 Months9.7312.494.517.5719,315,461-4.67-48.0%
6 Months3.787417.492.108.8021,647,8871.2733.6%
1 Year0.3317.490.2667.1514,309,6704.731,433.33%
3 Years10.5617.490.25436.955,246,176-5.50-52.08%
5 Years21.345525.080.25436.993,188,349-16.29-76.29%

Vaxart Description

Vaxart Inc is a biopharmaceutical company. It is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The company has three product candidates which are; Influenza, Norovirus and RSV Vaccine, an oral fusion protein inhibitor for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in for condyloma caused by human papillomavirus.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.